van Amstel Arnout Ploos

CIK: 0001870330

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZURA

Zura Bio Ltd

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ZURA
Zura Bio Ltd
May 21, 2025
Award(A)
Share Option (Right to Buy)
Direct
51K shares-
ZURA
Zura Bio Ltd
Dec 9, 2024
Award(A)
Share Option (Right to Buy)
Direct
117K shares-

		Type	Shares	Price		Ownership
May 21, 2025	ZURA Zura Bio Ltd	Award(A) Share Option (Right to Buy)	51,000	-	-	Direct
Dec 9, 2024	ZURA Zura Bio Ltd	Award(A) Share Option (Right to Buy)	117,000	-	-	Direct

1-2 of 2 transactions

About Ploos van Amstel Arnout

Ploos van Amstel Arnout (SEC CIK 0001870330) files insider reports with the SEC as Director of Zura Bio Ltd (ZURA).

Signal8 holds 2 ownership filings by Ploos van Amstel Arnout, all Form 4s, filed between Dec 11, 2024 and May 22, 2025. Those filings report 2 transactions, from Dec 9, 2024 to May 21, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Ploos van Amstel Arnout's filings is in HENDERSON, NV.

Recent filings by Ploos van Amstel Arnout

May 21, 2025: Grant or award of ZURA derivative securities (Form 4, code A).
Dec 9, 2024: Grant or award of ZURA derivative securities (Form 4, code A).

Other insiders filing for Zura Bio Ltd (ZURA)

Mathew Marlyn Teresa, VP, Principal Acctg. Officer
Jarrett Jennifer, Director
Thiara Parvinder, Director
Schoch Steven J, Director
Nirula Ajay, Director
Munshi Amit, Director

How to read Form 4 transaction codes